MDR 15.8% 55.0¢ medadvisor limited

Ann: MDR Record FY24 Performance with Positive EBITDA and NPAT, page-18

  1. 381 Posts.
    lightbulb Created with Sketch. 86
    Is it the AI Medication Advisor they are working on that is causing a few bids sneaky.png
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.